Koenig & Bauer AG
Koenig & Bauer AG (SKB.DE) Financial Performance & Income Statement Overview
Analyze Koenig & Bauer AG (SKB.DE) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Koenig & Bauer AG (SKB.DE) Income Statement & Financial Overview
View the income breakdown for Koenig & Bauer AG SKB.DE across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $252.20M | $454.80M | $287.60M | $278.80M |
| Cost of Revenue | $190.20M | $347.10M | $227.80M | $218.20M |
| Gross Profit | $62.00M | $107.70M | $59.80M | $60.60M |
| Gross Profit Ratio | $0.25 | $0.24 | $0.21 | $0.22 |
| R&D Expenses | $10.60M | $9.90M | $16.60M | $12.00M |
| SG&A Expenses | $64.10M | $74.90M | $67.50M | $69.70M |
| Operating Expenses | $74.70M | $84.90M | $59.80M | $81.70M |
| Total Costs & Expenses | $264.90M | $432.00M | $311.90M | $299.90M |
| Interest Income | $0.00 | $0.00 | $0.00 | $700000.00 |
| Interest Expense | $6.40M | $4.30M | $7.10M | $6.10M |
| Depreciation & Amortization | $10.90M | $11.80M | $10.90M | $11.30M |
| EBITDA | -$12.70M | $27.20M | -$24.30M | -$12.40M |
| EBITDA Ratio | -$0.05 | $0.06 | -$0.08 | -$0.04 |
| Operating Income | -$12.70M | $22.80M | -$24.30M | -$21.10M |
| Operating Income Ratio | -$0.05 | $0.05 | -$0.08 | -$0.08 |
| Other Income/Expenses (Net) | -$7.90M | -$6.60M | -$4.50M | -$8.70M |
| Income Before Tax | -$20.60M | $16.20M | -$28.80M | -$29.80M |
| Income Before Tax Ratio | -$0.08 | $0.04 | -$0.10 | -$0.11 |
| Income Tax Expense | $2.60M | $8.70M | -$800000.00 | $2.90M |
| Net Income | -$23.20M | $7.40M | -$28.10M | -$32.70M |
| Net Income Ratio | -$0.09 | $0.02 | -$0.10 | -$0.12 |
| EPS | -$1.40 | $0.45 | -$1.70 | -$1.98 |
| Diluted EPS | -$1.40 | $0.45 | -$1.70 | -$1.98 |
| Weighted Avg Shares Outstanding | $16.57M | $16.53M | $16.53M | $16.52M |
| Weighted Avg Shares Outstanding (Diluted) | $16.57M | $16.53M | $16.53M | $16.52M |
Over the past four quarters, Koenig & Bauer AG demonstrated steady revenue growth, increasing from $278.80M in Q2 2024 to $252.20M in Q1 2025. Operating income reached -$12.70M in Q1 2025, maintaining a consistent -5% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$12.70M, reflecting operational efficiency. Net income dropped to -$23.20M, with EPS at -$1.40. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan